Ventus Therapeutics is using computational tools to unlock elusive drug targets that address human disease.
Leadership
Marcelo Bigal
Fund
SVF2
Status
Private
Sector
Health Tech
Region
Americas
Insights
Q&A
Marcelo Bigal: Always putting patients first
It comes down to everyone understanding Ventus Therapeutics’ core mission